Between two strains: Probiotic decision making

Between two strains: Probiotic decision making

Selecting which probiotic pressure to incorporate in your new product is vital. Consumer expectations are excessive. Technical and regulatory calls for could be complicated—exhausting to know and to navigate. If you’re not a probiotic-ologist, the place do you begin? At the start, in fact! Successfully launching and/or rising a probiotic model requires an intensive understanding of the whole probiotic growth course of: pressure choice and characterization, scientific trials, manufacturing, packaging, labeling, regulatory necessities, and a lot extra. It could be overwhelming. 
Join us for a dialogue that includes IFF’s Amy Smith, PhD, Global Regulatory Strategy Lead and IPA President; and Mark Haupt, MD, Chief Medical Officer. In this webinar they’ll share their views on key factors to contemplate when growing and launching probiotic merchandise. 
Takeaways: 
Pick up vital suggestions to assist navigate the dynamic dietary complement regulatory panorama, higher positioning your model for future development, acquisition and retail acceptance. 
Learn extra about how greatest to make use of outcomes from scientific trials to information profit statements and ship on shopper expectations. 
Understand the crew and data wanted to ship a high quality probiotic to customers.
Get a sneak peek at some new shopper analysis insights about probiotics from a latest examine.
Moderator:

Karen RatermanAssociate Director, Content Marketing, Natural Products Insider
Speakers:

Mark HauptChief Medical Officer, IFF Health 
After receiving his medical coaching on the Northwestern University Feinberg School of Medicine, Dr. Haupt pursued a profession in pediatric pulmonary medication. His scholarly actions targeted on bettering dietary outcomes for youngsters with cystic fibrosis through pancreatic enzyme alternative remedy. Dr. Haupt in the end transitioned to the pharma/biotech business the place he’s continued to give attention to complicated inflammatory syndromes of the digestive tract. He is captivated with bettering well being by vitamin, customized medication and knowledge.

Amy Smith Director of Global Regulatory Strategy, IFF Health
Dr. Smith started her journey as a microbiologist with a doctoral diploma in microbiology from Louisiana State University, the place she minored in virology and molecular biology. After years conducting analysis on microbial pathogenesis and molecular detection strategies, Dr. Smith started a profession at DuPont, main enterprise enlargement inside molecular diagnostics earlier than transitioning to guide the probiotics international regulatory technique for DuPont Nutrition & Health. In her present position, she leads international regulatory efforts for all IFF Health ingredient dietary complement functions. She additionally serves as President on the chief board of administrators of the International Probiotics Association (IPA). Amy’s potential to know science, regulation, and real-world business promotes a forward-thinking purposeful ingredient platform for the success of IFF Health, all on the present tempo of immense business development.

https://www.naturalproductsinsider.com/components/between-two-strains-probiotic-decision-making-non-probiotic-ologist-webinar

You May Also Like

About the Author: Amanda